MAPT and tauopathy: The non-conventional release of protein Tau then explains (i) its presence in CSF, even in the absence of neuronal damage [69]; (ii) its eventual contribution to the regional propagation of tauopathy [70]–[72]; and (iii) the beneficial effects of Tau-directed vaccination, which then acts not on an intracellular, but on an extracellular target.